Quarterly ResultAug 5, 2026, 06:37 AM
Cencora Q3 Revenue $84.8B, Adj. EPS $4.48; Raises FY26 Guidance
AI Summary
Cencora, Inc. reported strong fiscal third quarter 2026 results, with revenue increasing 5.1% year-over-year to $84.8 billion. GAAP diluted EPS grew 11.9% to $3.94, and adjusted diluted EPS increased 12.0% to $4.48. The company raised its fiscal year 2026 adjusted diluted EPS guidance to a range of $17.75 to $17.95 and repurchased $1 billion in shares during the quarter. Cencora also declared a quarterly cash dividend of $0.60 per common share.
Key Highlights
- Q3 2026 Revenue increased 5.1% year-over-year to $84.8 billion.
- GAAP Diluted EPS was $3.94, an 11.9% increase from prior year.
- Adjusted Diluted EPS rose 12.0% to $4.48.
- Raised Fiscal 2026 Adjusted Diluted EPS guidance to $17.75-$17.95.
- Repurchased $1 billion of shares in the third fiscal quarter.
- Declared a quarterly cash dividend of $0.60 per common share.
- U.S. Healthcare Solutions revenue grew 4.9% to $74.9 billion.
- International Healthcare Solutions revenue increased 5.9% to $7.7 billion.
Price Impact
More from COR